Telegram RegisterThe public register of Telegram
Telegram profile photo for @TUMSPharmaBridge

Channel

@TUMSPharmaBridge

@TUMSPharmaBridge

On this record: Growth · Engagement · Reactions · Posts · Citations · Cite this entry

448subscribers

+32 since we began measuring on 3 September 2026

Risers and fallers across the register · movement among entries of Under 1,000.

Register entry

Telegram ID-1004364984625
TypeChannel
Username@TUMSPharmaBridge
Created18 August 2026measured — dated from the channel’s first post
First recorded3 September 2026
Last confirmed live13 September 2026
Measurements held4
Confirmed unchanged1 time, most recently 13 September 2026
On Telegramt.me/TUMSPharmaBridge

Growth

4164484323 September 2026 — 416 subscribers3 September 2026 — 416 subscribers5 September 2026 — 428 subscribers13 September 2026 — 448 subscribers3 September 202613 September 2026
4 measurements spanning 10 days, net +32. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 411–453 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
13 Sept 2026, 16:36448+20
5 Sept 2026, 21:41428+12
3 Sept 2026, 23:22416no change
3 Sept 2026, 22:47416first reading

Engagement

8 posts held, back to 18 August 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.

ERR · 30 days
355.1%
avg views ÷ 448 subscribers
Avg views / post
1,590
3 posts measured
Reaction rate
0.21%
reactions ÷ views · ER floor
Posts in window
3
of 8 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views — note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.

What these figures were computed from
WindowRolling 30 days · latest post in window 3 September 2026
Posts held8 (18 August 20263 September 2026)
Views total4,773
Reactions total10
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken3 Sept 2026, 23:22 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

Reaction mix

22 reactions across 6 posts, in 4 distinct kinds. The most used accounts for 68.2% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
1568.2%
🔥522.7%
🤩14.55%
🥰14.55%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 7 of the 8 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 22 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 8 most recent posts we hold, published 18 August 2026 to 3 September 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

3 Sept 2026, 16:16 UTC341 views1 reactionsread 3 September 2026
Photo

فقط ۲ روز تا پایان فرصت ارسال ایده‌تون باقی مونده!! ایده‌ای داری که فکر می‌کنی می‌تونه یک مسئله واقعی در صنعت دارو رو حل کنه؟ 👀💡 اینجا لازم نیست از همون اول یک طرح کامل، محصول آماده یا بیزنس‌پلن چندصفحه‌ای داشته باشی. کافیه بتونی خیلی ساده بگی: 🔸 شما چه کسی یا چه تیمی هستید؟ 🔸 چه مشکلی رو دیدید؟ 🔸 راه‌حل یا ایده‌تون چیه؟ 🔸 برای ادامه مسیر، از صنعت چه کمکی می‌خواید؟ ایده‌ها می‌تونن از بخش‌های مختلف داروسازی باشن.

🥰1

2 Sept 2026, 12:47 UTC932 views4 reactionsread 3 September 2026
Photo

💊 یک روز از زندگی یک داروساز واقعاً چطور می‌گذره؟ وقتی اسم R&D، تضمین کیفیت، رگولاتوری، مارکتینگ یا بخش‌های مختلف صنعت دارو رو می‌شنویم، شاید درباره‌شون چیزهایی بدونیم؛ اما تا وقتی وارد اون محیط نشیم، خیلی وقت‌ها نمی‌دونیم واقعاً چه کاری قراره انجام بدیم. برای همین در اولین برنامه از مجموعه TUMS Pharma Career Clinic می‌خوایم بریم سراغ خودِ داروسازهایی که این مسیرها رو تجربه کردن. در برنامه «یک روز از زندگی یک دارو

🔥3🤩1

24 Aug 2026, 16:44 UTC≈3,500 views5 reactionsread 3 September 2026
Photo

ایده‌ای داری که فکر می‌کنی می‌تونه یک مسئله واقعی در صنعت دارو رو حل کنه؟ 👀💡 اینجا لازم نیست از همون اول یک طرح کامل، محصول آماده یا بیزنس‌پلن چندصفحه‌ای داشته باشی. کافیه بتونی خیلی ساده بگی: 🔸 شما چه کسی یا چه تیمی هستید؟ 🔸 چه مشکلی رو دیدید؟ 🔸 راه‌حل یا ایده‌تون چیه؟ 🔸 برای ادامه مسیر، از صنعت چه کمکی می‌خواید؟ ایده‌ها می‌تونن از بخش‌های مختلف داروسازی باشن؛ از مواد مؤثره و حدواسط‌های دارویی، فرمولاسیون و بسته‌

5

22 Aug 2026, 16:46 UTC≈3,120 views2 reactionsread 3 September 2026
Photo

فارمکس امسال قراره برای ما فقط غرفه‌گردی نباشه! 💊 توی غرفه TUMS PharmaBridge می‌خوایم دور هم جمع بشیم، درباره مسیرهای واقعی ورود به صنعت دارو حرف بزنیم، با آدم‌هایی که توی بخش‌های مختلف صنعت کار می‌کنن آشنا بشیم و جواب خیلی از سؤال‌هامون درباره آینده شغلی داروسازی رو پیدا کنیم. برنامه‌هامون هم فقط سخنرانی و ارائه نیست؛ از چالش تولید ایده و حل مسئله‌های واقعی صنعت گرفته تا کلینیک مسیر شغلی، گفت‌وگوهای کوتاه و کاربرد

🔥2

21 Aug 2026, 10:22 UTC508 views2 reactionsread 3 September 2026
Photo

یک بازی‌جدی دیگر از کافه‌این! این‌بار بازی‌ای برای یادگیری دانش کنترل کیفیت و سلامت زنجیره‌ی تامین در دل یک ماجرای کارآگاهی در دوران قاجار و در مکان مدرسه‌ی دارالفنون! محل آغاز داستان آکادمیک داروسازی و پزشکی در ایران! از اول تا پنجم شهریور ما هر روز صبح تا ظهر در ساختمان تاریخی دارالفنون منتظر شما هستیم تا در یکی از این روزها، باهم پرونده‌های واقعیِ تقلبات دارویی را رمزگشایی کنیم و اصول کنترل کیفیت و سلامت زنجیره

2

20 Aug 2026, 12:58 UTC517 views8 reactionsread 3 September 2026
Photo

همه‌چیز از دیدن یک کروموزوم غیرعادی زیر میکروسکوپ شروع شد؛ مشاهده‌ای که سال‌ها بعد به ساخت یکی از مهم‌ترین داروهای هدفمند سرطان رسید. داستان imatinib، داستان همکاری پژوهشگران دانشگاه، پزشکان و صنعت داروست؛ همکاری‌ای که یک یافته علمی را به درمانی مؤثر برای بیماران تبدیل کرد. این پست، روایت مسیری است که CML را برای بسیاری از بیماران از یک سرطان کشنده به بیماری قابل‌کنترل تبدیل کرد. ورق بزنید و داستان imatinib را بخو

8

18 Aug 2026, 19:22 UTC≈4,390 views0 reactionsread 3 September 2026
Photo

تا حالا برات سؤال بوده که یک داروساز در صنعت دقیقاً چه کارهایی می‌تونه انجام بده؟🤔 از کجا باید فرصت کارآموزی پیدا کرد؟🧐 چطور می‌شه با شرکت‌های دارویی ارتباط گرفت و با مسیرهای شغلی مختلف آشنا شد؟🙃 شبکه ارتباطی TUMS PharmaBridge راه افتاده تا دانشجوهای دانشکده داروسازی تهران را یک قدم به دنیای واقعی صنعت دارو نزدیک‌تر کند. اینجا قراره از فرصت‌هایی باخبر بشید که معمولاً به‌سادگی پیدا نمی‌شن: 🔹 کارآموزی و فرصت‌های همک

Showing the 8 most recent of 8 posts we hold for @TUMSPharmaBridge. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 2 registered channels — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Names

Channels on the register whose handles appear in this channel's posts.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 13 September 2026 — this entry's latest reading, not the date you are reading this.

“@TUMSPharmaBridge” (@TUMSPharmaBridge), 448 subscribers as measured 13 September 2026. Telegram Register, tgregister.com/channel/TUMSPharmaBridge.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.